Explore

Capbase

Clover Biopharmaceuticals, Ltd. — Funding, Investors & Profile — Capbase

Private

Private securities offering disclosed via SEC Form D.

Biotechnology

$3.6MSource: [SEC]Total raised

UndisclosedSource: [SEC]Last valuation

Clover Biopharmaceuticals, Ltd. filed a Form D notice of exempt offering with the SEC.

1 rounds

No investors recorded yet for Clover Biopharmaceuticals, Ltd..

Leadership

Peng LiangExecutive OfficerSince 2026Source: [SEC]

Joshua LiangExecutive OfficerSince 2026Source: [SEC]

Showing 2 of 3 — any approved contribution unlocks every profile for 30 days.Sign in to unlock

Clover Biopharmaceuticals, Ltd. has no recorded acquisitions.

Still private — no exit on record.

No diversity signals recorded yet for Clover Biopharmaceuticals, Ltd..

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.